Combination Therapy for Pancreatic Cancer: Anti-PD-(L)1-Based Strategy

The authors highlight potential adverse effects of accumulative combination, and further points out future direction in optimization of combination, including targeting post-translational modification of PD-(L)1 and improving precision of treatment.